Medical Countermeasures Unlocking a New Target Against Crimean-Congo Hemorrhagic Fever VirusGlobal Biodefense StaffJuly 3, 2025
Pathogens Enzyme-Based Anthrax Therapy Shows Promise in Preclinical TrialsGlobal Biodefense StaffJune 17, 2025
Medical Countermeasures Novel Oral Chitosan-Based Compound Shows Promise for Radiological Emergency ResponseGlobal Biodefense StaffJune 12, 2025
Pharma Leaders Issue Joint Declaration on Combating Antimicrobial Resistance Antimicrobial Resistance January 21, 2016 …
Profectus BioSciences Initiates Ebola Vaccine Phase 1 Trial Medical Countermeasures January 20, 2016 …
NIAID Awards 5M for Non-Traditional Bacterial Infection Treatments Antimicrobial Resistance January 12, 2016 …
JP Morgan Conference Turns San Francisco into Biotech Convergence Zone Biodetection December 28, 2015 …
Profectus Awarded Grant to Develop Select Agent Countermeasures Contracts + Grants December 9, 2015 …
